ASP Isotopes Inc. (NASDAQ:ASPI) Sees Large Growth in Short Interest

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of a significant growth in short interest in November. As of November 30th, there was short interest totalling 6,450,000 shares, a growth of 15.8% from the November 15th total of 5,570,000 shares. Based on an average daily volume of 4,620,000 shares, the days-to-cover ratio is presently 1.4 days. Currently, 14.1% of the company’s stock are sold short.

Hedge Funds Weigh In On ASP Isotopes

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASPI. B. Riley Wealth Advisors Inc. bought a new position in shares of ASP Isotopes in the 3rd quarter valued at about $42,000. Fielder Capital Group LLC acquired a new stake in ASP Isotopes during the second quarter worth approximately $55,000. The Manufacturers Life Insurance Company bought a new position in shares of ASP Isotopes in the third quarter worth $52,000. KKM Financial LLC raised its position in shares of ASP Isotopes by 66.2% in the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after buying an additional 9,000 shares in the last quarter. Finally, Sanctuary Advisors LLC bought a new stake in ASP Isotopes during the third quarter worth $66,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Trading Up 14.4 %

Shares of ASP Isotopes stock traded up $0.63 during trading on Friday, hitting $5.00. 5,364,095 shares of the company were exchanged, compared to its average volume of 1,872,946. The firm has a market capitalization of $356.95 million, a P/E ratio of -8.20 and a beta of 3.27. The firm’s fifty day moving average price is $5.62 and its 200 day moving average price is $3.91. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes has a 1-year low of $1.65 and a 1-year high of $9.33.

Analyst Ratings Changes

A number of research analysts have recently commented on ASPI shares. Canaccord Genuity Group started coverage on ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective on the stock. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.